1. Home
  2. RGEN vs AFRM Comparison

RGEN vs AFRM Comparison

Compare RGEN & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • AFRM
  • Stock Information
  • Founded
  • RGEN 1981
  • AFRM 2012
  • Country
  • RGEN United States
  • AFRM United States
  • Employees
  • RGEN N/A
  • AFRM N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • AFRM Business Services
  • Sector
  • RGEN Health Care
  • AFRM Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • AFRM Nasdaq
  • Market Cap
  • RGEN 7.6B
  • AFRM 19.8B
  • IPO Year
  • RGEN N/A
  • AFRM 2021
  • Fundamental
  • Price
  • RGEN $156.55
  • AFRM $55.35
  • Analyst Decision
  • RGEN Buy
  • AFRM Buy
  • Analyst Count
  • RGEN 12
  • AFRM 18
  • Target Price
  • RGEN $187.44
  • AFRM $58.76
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • AFRM 6.0M
  • Earning Date
  • RGEN 02-19-2025
  • AFRM 02-06-2025
  • Dividend Yield
  • RGEN N/A
  • AFRM N/A
  • EPS Growth
  • RGEN N/A
  • AFRM N/A
  • EPS
  • RGEN N/A
  • AFRM N/A
  • Revenue
  • RGEN $633,513,000.00
  • AFRM $2,524,931,000.00
  • Revenue This Year
  • RGEN $2.28
  • AFRM $36.03
  • Revenue Next Year
  • RGEN $9.88
  • AFRM $22.91
  • P/E Ratio
  • RGEN N/A
  • AFRM N/A
  • Revenue Growth
  • RGEN N/A
  • AFRM 46.55
  • 52 Week Low
  • RGEN $113.50
  • AFRM $22.25
  • 52 Week High
  • RGEN $211.13
  • AFRM $73.34
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • AFRM 37.97
  • Support Level
  • RGEN $149.15
  • AFRM $52.65
  • Resistance Level
  • RGEN $160.64
  • AFRM $68.20
  • Average True Range (ATR)
  • RGEN 5.96
  • AFRM 2.97
  • MACD
  • RGEN 0.91
  • AFRM -1.50
  • Stochastic Oscillator
  • RGEN 79.57
  • AFRM 17.37

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About AFRM Affirm Holdings Inc.

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

Share on Social Networks: